BRADBURY DANIEL 4

What Happened
Daniel Bradbury, a director of Vivani Medical, was granted a derivative award for 36,516 shares on 2026-06-24 at an implied value/price of $1.22 per share, totaling about $44,550. The award was granted under the company’s Non-Employee Director Compensation Policy and is a compensation grant (not an open-market purchase or sale).

Key Details

• Transaction date and type: 2026-06-24 — Grant/award of derivative securities (code A).
• Price/value: $1.22 per share; aggregate value reported ≈ $44,550.
• Vesting: The award vests in full on the earlier of (i) the first anniversary of the grant or (ii) the next annual meeting of stockholders, subject to continued service (see footnote F2).
• Policy: Award made pursuant to the issuer’s Non-Employee Director Compensation Policy (footnote F1).
• Shares owned after transaction: Not reported in this Form 4.
• Filing timeliness: Reported on 2026-06-25 for a 2026-06-24 transaction — filed within the normal Form 4 reporting window.

Context
This was a routine director compensation award of derivative securities (likely stock options or restricted units) rather than a market purchase or sale; the grant does not indicate an immediate cash transaction or sale of shares. Such awards are common for non-employee directors and vest over time or by the next shareholder meeting per the stated terms.